Scientists finally uncover why promising cancer drugs keep failing
Researchers at the Max Planck Institute of Immunobiology and Epigenetics have identified a critical distinction between two closely related BET proteins, ...
Every story
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2641–2664 of 3,535
TRICARE Now Covers Online Therapy in New York — $0 Copay for Active-Duty Families Through MMHC
Manhattan Mental Health Counseling (MMHC) has expanded its telehealth services to accept TRICARE Select and TRICARE Reserve Select, providing military f...
Goodbye colonoscopy? New stool test detects 90% of colorectal cancers
Researchers at the Université de Genève have developed a groundbreaking stool test that detects 90% of colorectal cancers, leveraging advanced machine l...
significant
Author Correction: Multi-omic profiling reveals age-related immune dynamics in healthy adults
Correction has been issued for the article titled “Multi-omic profiling reveals age-related immune dynamics in healthy adults,” originally published in Nature...
landmark
Determining six-month prognosis among people with dementia living in care homes: a systematic review of prognostic tools
A systematic review led by researchers sought to evaluate prognostic tools for predicting 6-month mortality in individuals with dementia residing in car...
significant
Effectiveness of non-pharmacological and pharmacological interventions on delirium duration in older adults with delirium: a systematic review and meta-analysis of randomised controlled trials
A systematic review and meta-analysis led by researchers aimed to evaluate the efficacy of both non-pharmacological and pharmacological interventions fo...
significant
Muscle mass, function and performance across the adult lifespan: the study of muscle, mobility and ageing
D₃-creatine (D₃Cr) dilution emerges as a robust biomarker for assessing total body skeletal muscle mass, revealing critical insights into muscle function and...
Prostate ageing across the adult lifespan: population MRI evidence from 30 000 men
Automated segmentation of whole-body MRI data from the UK Biobank has enabled researchers to quantify prostate volume in 30,616 men, revealing significant ins...
Treatment-modifying effects of frailty on stroke reperfusion therapy outcomes: a systematic review and meta-analysis
A recent systematic review and meta-analysis has established a significant correlation between pre-stroke frailty and adverse outcomes following reperfusi...
significant
"Could a new pill help you lose weight safely?"
Foundayo is a new oral medication for weight loss that may help you lose significant pounds and improve heart health.
large human triallandmark
Foundayo™ (orforglipron), la nueva pastilla GLP-1 de Lilly que se administra por vía oral para la pérdida de peso, ahora está disponible en Estados Unidos.
Eli Lilly has launched Foundayo™ (orforglipron), an oral GLP-1 receptor agonist approved by the FDA for weight management in adults with obesity or overweig...
significant
Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
Strata Critical Medical, Inc. (Nasdaq: SRTA) has announced its participation in the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026, at 1:30...
eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals
eHealth Exchange™ has achieved a significant milestone in advancing interoperability by successfully demonstrating secure, standards-based patient access capabi...
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
Emergent BioSolutions has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN® Nasal Spray for the province's Take-Home Nal...
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Health Canada has approved EMPAVELI® (pegcetacoplan), the first treatment specifically for C3 glomerulopathy (C3G) and primary immune-complex membranoprolifer...
Sobi reçoit l’autorisation par Santé Canada pour EMPAVELIMD (pegcétacoplan) dans le traitement de la GC3 et de la GNMP-CI primitive.
EMPAVELIMD (pegcétacoplan) has received approval from Health Canada as the first treatment for adults and pediatric patients aged 12 and older with C3 glo...
Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting
Verrica Pharmaceuticals has announced the acceptance of a late-breaking abstract detailing Phase 2 exploratory data for VP-315, a novel oncolytic peptide ai...
Neuronal APOE4-induced early hippocampal network hyperexcitability in Alzheimer’s disease pathogenesis
Young APOE4 knockin (E4-KI) mice exhibit hippocampal region-specific network hyperexcitability, a phenomenon that predicts later cognitive deficits. This stud...
noteworthy
The case for space as a model of accelerated aging
NASA's exploration of spaceflight as a model for human aging reveals significant insights into the biological processes underlying aging. The study highligh...
noteworthy
ClinNEXUS to Participate as Featured Speaker in Suncoast Ventures Gateway Conference on Healthcare Innovation
ClinNEXUS, a data-driven healthcare company, is set to play a pivotal role at the upcoming Suncoast Ventures 2nd Annual Gateway Conference on April 14-15 in...
Medical Centre in Blacktown goes Bulk Billed
Kildare Road Medical Centre in Blacktown, Australia, has reinforced its commitment to community healthcare by continuing its participation in the Australian G...
Arg-1 Makes Macrophages More Inflammatory, Impairing Cartilage Regeneration with Age
Researchers have identified Arginase-1 (Arg-1) as a pivotal gene influencing macrophage behavior in cartilage, revealing its role in the age-related decline...
In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient
Miltenyi Biomedicine's zorpocabtagene-autoleucel (zorpo-cel), a CD19-targeting CAR-T cell therapy, has demonstrated remarkable efficacy by treating a patien...
landmark
Loyola University New Orleans College of Nursing and Health Awarded $2.85 Million to Expand Nursing Education and Training
Loyola University New Orleans has secured $2.85 million in federal funding aimed at enhancing nursing education within its College of Nursing and Health. Th...